Post-earnings recap
Reported
Wed, Jul 15, 2026
EPS actual
$7.45
EPS est.
$6.18
EPS surprise
+20.63%
1-day move
-8.54%
Elevance Health, Inc. is a major player in the health care sector, specifically in managed health care. The company provides health insurance and related services, making it a key component of the health care system, especially as health care costs and access continue to be significant issues for consumers and policymakers.
Last quarter
In Q1 2026, Elevance Health reported an EPS of $12.58, significantly exceeding expectations by 17.75%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.
Management promises and guidance
EPS beat streak
4Q
EPS beat rate
63%
Avg EPS surprise
+6.04%
Avg 1-day reaction
-2.71%
Analysts are generally optimistic about Elevance Health's upcoming earnings, expecting solid EPS and revenue figures. The company has a strong track record of beating earnings estimates, which could bolster investor confidence.
Bull case
If Elevance can exceed the EPS estimate and demonstrate strong revenue growth, it may signal robust operational performance and market share gains.
Bear case
Conversely, if the company misses its earnings target or shows signs of declining membership or revenue, it could lead to a significant sell-off.
Key metrics to watch
EPS
$6.21Earnings per share is a critical measure of profitability and helps investors gauge the company's financial health.
Revenue
$48.6BTotal revenue indicates the company's ability to generate sales and is essential for assessing growth.
The print will turn on these.
Q1
Will EPS exceed the consensus estimate of $6.21?
A beat on EPS could reinforce investor confidence and validate the company's operational strategies.
Q2
What are the membership trends and revenue growth rates?
Understanding these metrics is crucial for assessing the company's market position and growth potential.
—
Est. EPS
$1.15
Est. Rev
$178M
Impl. Move
±7.1%
Why consensus could be wrong
The consensus may underestimate Elevance's ability to leverage digital health initiatives, which could drive higher membership and revenue growth.
Supporting evidence
The company has a history of exceeding EPS estimates, suggesting potential for strong results.
Recent investments in technology may yield better-than-expected engagement and retention rates.
Options pricing indicates a higher expected move, reflecting market anticipation of significant developments.
Key risk
If membership growth exceeds expectations, it could invalidate bearish sentiment and drive the stock higher.
Pre-commit to what would confirm each case.
This quarter, the focus is on whether Elevance can maintain its growth trajectory amidst a competitive health care landscape.
Bull confirmed if
An EPS of $6.50 or higher would confirm strong operational performance and market confidence.
Bear confirmed if
An EPS below $6.06 would indicate potential challenges in profitability and could lead to negative sentiment.
What the market is pricing for the move.
Implied Move
±9.58%
Historical Avg
±5.4%
The options market is pricing in a substantial move, suggesting that investors expect volatility around the earnings announcement.
Options are pricing ±9.6% while ELV has averaged ±5.4% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
27.9%
Smart-money positioning from the most recent 13F filings.
Institutional
94.13%
of float
Insider
0.19%
of float
Holders
2,159
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
18,991,090 sh · $7.7B
8.76%
-4.5%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Elevance beats expectations, history suggests a potential average one-day move of +0.64%, confirming strong operational health.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors await further commentary on growth strategies.
Miss
A miss could lead to a significant drop, with historical patterns indicating an average one-day decline of -11.40%.
The lines on the call that would change the story.
Vanguard Capital Management LLC
14,058,204 sh · $5.7B
6.48%
-2.0%
State Street Corporation
10,426,610 sh · $4.2B
4.81%
1.3%
Wellington Management Group, LLP
9,213,513 sh · $3.7B
4.25%
12.0%
Vanguard Portfolio Management LLC
6,214,356 sh · $2.5B
2.87%
-2.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.